Clinical Trials Logo

Clinical Trial Summary

Revival of significance and the emergent market of herbal medicinal products necessitate strong commitment by the stakeholders to safeguard the end users. The variability in the concentrations of constituents of plant material, coupled with the variety of extraction techniques and processing steps used by different manufacturers, results in distinct inconsistency in the quality of herbal products. The present study will be directed to a polyherbal formulation Entoban which integrates an outstanding blend of herbs that have been used for decades to eradicate microorganisms and worms from gastrointestinal tract. It is the combination of Holarrhena antidysenterica, Berberis aristata, Symplocos racemosa, Querecus infectoria and Helicteres isora. The current study would target the chemical assessment, pharmacological and comparative clinical evaluation of Entoban to assure its safety and efficacy.


Clinical Trial Description

The study will be adopted to compare the efficacy, tolerability, and safety of Entoban using Metronidazole DS as a comparator. The study was carried out in XYZ hospital from Jan 2015 to Dec 2015. The participants will be selected on the basis of inclusion and exclusive criteria. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02642250
Study type Interventional
Source Shifa Ul Mulk Memorial Hospital
Contact
Status Completed
Phase Phase 2/Phase 3
Start date January 2015
Completion date December 2015

See also
  Status Clinical Trial Phase
Completed NCT03269305 - An Audit on Management of Chronic Diarrhea
Completed NCT03876717 - Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea Phase 4
Not yet recruiting NCT03598010 - Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea N/A
Completed NCT05690321 - Opium Tincture Against Chronic Diarrhea - Patients Phase 2
Terminated NCT01866774 - Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service N/A
Completed NCT01545063 - CAre of Patients With PArenteral Nutrition At Home N/A
Completed NCT05702190 - Opium Tincture Against Chronic Diarrhea - Healthy N/A
Not yet recruiting NCT05811091 - Pathological Patterns in Chronic Diarrhea With Normal Colonoscopy
Not yet recruiting NCT05724381 - Auramine Phenol Staining Technique for Revealing Different Coccidian Parasites
Recruiting NCT01070277 - Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea N/A
Recruiting NCT06152289 - Development of New Diagnostic Tools in Capsule Endoscopy
Completed NCT03270085 - Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption Phase 2
Completed NCT05130047 - Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) Phase 2
Recruiting NCT03261297 - Epidemiology of Chronic Diarrhea Among Children Admitted to Gastroenterology Unit at Assuit University Children Hospital N/A
Completed NCT01840891 - Secondary Lactose Intolerance Due to Chronic Norovirus Infection N/A
Completed NCT03143517 - Fecal Calprotectin Collection Protocol